Formosa Pharmaceuticals, Inc. (TPE:6838)

Formosa Pharmaceuticals Revenue

Formosa Pharmaceuticals had revenue of 594.00K TWD in the quarter ending March 31, 2025, a decrease of -99.54%. This brings the company's revenue in the last twelve months to 16.15M, down -89.84% year-over-year. In the year 2024, Formosa Pharmaceuticals had annual revenue of 143.36M with 359.89% growth.

• Revenue (ttm): 16.15M
• Revenue Growth: -89.84%
• P/S Ratio: 333.74
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	143.36M	112.18M	359.89%
Dec 31, 2023	31.17M	29.86M	2,270.49%
Dec 31, 2022	1.32M	-27.21M	-95.39%
Dec 31, 2021	28.53M	-	-
Dec 31, 2020	-	-	-